NO-Releasing Nanoparticles Ameliorate Detrusor Overactivity in Transgenic Sickle Cell Mice via Restored NO/ROCK Signaling.

The Journal of Pharmacology and Experimental Therapeutics
Serkan KarakusArthur L Burnett

Abstract

Sickle cell disease (SCD) is associated with overactive bladder (OAB). Detrusor overactivity, a component of OAB, is present in an SCD mouse, but the molecular mechanisms for this condition are not well-defined. We hypothesize that nitric oxide (NO)/ ras homolog gene family (Rho) A/Rho-associated kinase (ROCK) dysregulation is a mechanism for detrusor overactivity and that NO-releasing nanoparticles (NO-nps), a novel NO delivery system, may serve to treat this condition. Male adult SCD transgenic, combined endothelial NO synthases (eNOSs) and neuronal NOS (nNOS) gene-deficient (dNOS-/-), and wild-type (WT) mice were used. Empty nanoparticle or NO-np was injected into the bladder, followed by cystometric studies. The expression levels of phosphorylated eNOS (Ser-1177), protein kinase B (Akt) (Ser-473), nNOS (Ser-1412), and myosin phosphatase target subunit 1 (MYPT1) (Thr-696) were assessed in the bladder. SCD and dNOS-/- mice had a greater (P < 0.05) number of voiding and nonvoiding contractions compared with WT mice, and they were normalized by NO-np treatment. eNOS (Ser-1177) and AKT (Ser-473) phosphorylation were decreased (P < 0.05) in the bladder of SCD compared with WT mice and reversed by NO-np. Phosphorylated MYPT1, a ma...Continue Reading

References

Mar 1, 1997·The Journal of Urology·R S SutherlandD S Bredt
Feb 1, 1997·Journal of Muscle Research and Cell Motility·P J GallagherJ T Stull
Sep 3, 1998·The Journal of Biological Chemistry·U Laufs, J K Liao
Nov 24, 1999·The Journal of Urology·H OzawaN Yoshimura
Apr 6, 2000·American Journal of Physiology. Renal Physiology·J P LavelleG Apodaca
Jul 14, 2000·The Journal of Urology·R K PanditaK E Andersson
Aug 24, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·K PerssonK E Andersson
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·K Joseph HurtArthur L Burnett
Jul 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Tsuyoshi MorishitaNobuyuki Yanagihara
Sep 22, 2009·The Journal of Sexual Medicine·George HanKelvin P Davies
May 1, 2010·Neurourology and Urodynamics·Paul AbramsAlan Wein
Sep 6, 2011·European Heart Journal·Ulrich Förstermann, William C Sessa
Jan 24, 2012·The Journal of Urology·Mariana Lima PortocarreroUbirajara Barroso
Jan 26, 2012·Neurourology and Urodynamics·E MengA F Brading
Sep 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·K Joseph HurtArthur L Burnett
Mar 28, 2013·Cardiovascular Diabetology·Figen Amber CicekBelma Turan
Apr 15, 2015·Neurourology and Urodynamics·Uzoma A AneleArthur L Burnett
Jul 15, 2016·Biophysical Journal·Krishna SriramDaniel M Tartakovsky
Feb 22, 2017·Naunyn-Schmiedeberg's Archives of Pharmacology·Andrzej WróbelPiotr Wlaź
Jan 14, 2018·Neurourology and Urodynamics·Lauren C PowellKatherine Gooch
Apr 28, 2018·The Journal of Sexual Medicine·Andrew DraganskiKelvin P Davies
Jun 20, 2019·American Journal of Physiology. Renal Physiology·Serkan KarakusArthur L Burnett

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.